ESRX : Analysis & Opinions

  1. Trade Healthcare Providers with this ETF

    February 27, 2015
    In good times and bad times one of the best sectors for retail investors to look into is the healthcare providers. Here's ...
  2. AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst ...

    January 19, 2015
    Approval was expected as the CHMP had provided a positive opinion late last year.
  3. Express Scripts Holding Company (ESRX): New Analyst Report from ...

    January 16, 2015
    Express Scripts Holding Company posted third-quarter 2014 earnings per share (excluding special items) of $1.29, in line ...
  4. AbbVie 2015 Earnings Guidance Projects Strong Y/Y Growth - Analyst ...

    January 9, 2015
    AbbVie (ABBV) announced that it expects earnings in the range of $4.25 to $4.45 per share for 2015.
  5. 3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog

    December 30, 2014
    Gilead (GILD) has been under pressure due to the pricing of its hepatitis C virus (HCV) treatments.
  6. After Gilead Sciences, Is it Time to Sell Biotech Stocks? - Analyst ...

    December 26, 2014
    Gilead Sciences Inc. has plunged approximately 15.8% after pharmacy benefit manager Express Scripts entered into an agreement ...
  7. 4 Biotech Stocks that Doubled in 2014 - Analyst Blog

    December 26, 2014
    Promising pipeline candidates, progress on the regulatory front and interesting research platforms helped these 4 biotech ...
  8. Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst ...

    December 23, 2014
    Pharmacy benefit manager Express Scripts (ESRX) announced an update to its National Preferred Formulary, which will now include ...
  9. Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs ...

    December 23, 2014
    Gilead shares fell more than 10 percent in Monday trading following news that AbbVie and Express Scripts signed an exclusive ...
  10. Stock Market News for December 23, 2014 - Market News

    December 23, 2014
    Benchmarks settled in the green for the fourth-straight session boosted by gains made by large-cap technology stocks
  11. McKesson CEO's $159 Million Pension: Should Shareholders Be Concerned?

    June 27, 2013
    Drug distribution company McKesson (NYSE:MCK) revealed in a June 21 regulatory filing that had CEO John Hammergren retired ...
  12. Walgreens' Analyst Meet Excerpts - Analyst Blog

    January 15, 2013
    Recently, Walgreens (WAG) discussed the current business environment and provided valuable insight into its future operations. ...
  13. Walgreens Discusses Growth Strategy - Analyst Blog

    January 14, 2013
    Recently, Walgreens (WAG) debriefed the investors on its growth strategy for fiscal 2013, while discussing the current business ...
  14. CVS Provides Impressive FY13 View - Analyst Blog

    December 14, 2012
    CVS Caremark Corporation (CVS), one of the largest domestic integrated pharmacy services providers, recently updated its ...
  15. Novo Nordisk A/S and More Big Movers in Healthcare on November ...

    November 6, 2012
    The Nasdaq remains relatively unchanged, the S&P 500 has climbed 0.4% and the Dow is trading up 0.6% so far today. The ...
  16. AvMed Extends HWAY SilverSneakers - Analyst Blog

    September 12, 2012
    Well-being enhancement company Healthways (HWAY) recently revealed that AvMed Health Plans has extended, by a couple of years ...
  17. AmerisourceBergen Looks Very Healthy

    June 18, 2012
    The drug distribution industry has great growth prospects and the leading players, including AmerisourceBergen, are trading ...
  18. CVS Caremark’s Dispensing A Modest Outlook

    February 10, 2012
    Much of CVS Caremark's future growth is already discounted in the share price.
  19. U.S. Stocks: Why America Is Recovering From The Debt Bust Faster ...

    January 24, 2012
    Private debt levels are helping America see a faster recovery from debt than Eurpoe is experiencing.
  20. 2011's Biggest Mergers and Acquisitions

    December 30, 2011
    M&A activity rebounded in a big way in 2011. Here's a look back at the biggest mergers and acquisitions during the year.
  21. What Is Walgreen's Next Trick?

    September 30, 2011
    Walgreen is doing okay today, but tomorrow is a much bigger question.
  22. CVS Still Needs to Prove Itself

    August 9, 2011
    A potential merger of two archrivals could increase the competitive environment for CVS significantly.
  23. Teva And Mylan Show Some Value Remains In Generics

    August 4, 2011
    These two generics companies seem to be heading in opposite directions, but the values are similar.
  24. 3 Stocks Swirling the Drain

    July 29, 2011
    Borders, the second largest bookstore in the US—like Blockbuster before it—failed to surprise Wall Street as it went under ...
  25. PBMs: Making The Most Of Generics

    February 3, 2011
    PBMs stand to benefit from the generic introduction of blockbuster drugs. Has the market fully discounted the opportunity?
  26. The IPO Crash Of Y2K

    July 21, 2009
    Performance of IPOs has been lackluster for the first part of this century. In the long run, are they worth the effort?
  27. Medco A Top Pharmacy Stock Pick

    March 25, 2009
    Medco looks to be the healthiest company among its peers, but is now the time to buy?
  28. Express Scripts: Trading Within A Symmetrical Triangle

    August 7, 2008
    Traders will keep a close watch on ESRX as it follows this well-formed pattern.
Trading Center